Access cutting-edge hemoglobin disorder treatment through this clinical trial at a research site in Memphis. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Memphis location
Preparing your pre-screening questions…
Access hemoglobin disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hemoglobin disorder treatment provided free
Check if you qualify for this hemoglobin disorder clinical trial in Memphis, TN
No-Cost Study Care
Local to Memphis
Convenient for TN residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a prospective, longitudinal, non-therapeutic study which includes routine assessment for long-term effects, as per FDA guidelines after receipt of an allogeneic HCT or autologous genetically modified cellular products for hemoglobin disorders. Primary objective: \- To provide long term follow up, for individuals with hemoglobin disorders undergoing allogeneic hematopoietic stem cell transplantation (HCT) or receipt of an autologous genetically modified cellular product to treat their hemoglobinopathy. For individuals receiving a genetically modified cellular product, this long term follow up study is in accordance with the guidelines provided by the Food and Drug Administration (FDA).
Sponsor: St. Jude Children's Research Hospital
Yes, this clinical trial (NCT06646640) has an active research site in Memphis, TN that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hemoglobin disorder treatment options in Memphis, TN, this clinical trial (NCT06646640) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemoglobin disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hemoglobin disorder clinical trials near you to find additional studies recruiting in your area.
See all sickle cell disease clinical trials recruiting in Memphis — not just this study.
Browse Sickle Cell Disease Trials in Memphis →